miR-33 b inhibits tumor EMT and migration in lung squamous cell carcinoma by targeting TWIST 1

Jingjing Qu,Min Li,Jian An,Wen Zhong,Qihua Gu,Liming Cao,Huaping Yang,Chengping Hu
2016-01-01
Abstract:Lung squamous cell carcinomais the mayor cause of cancer death. Tumor metastasis isthe important reason for lung cancer-associated mortality. Current researches have shown that microRNAs (miRNAs) in metastatic cancer may offer new insights for therapeutic control. Based on our previous study using gene chips, we selected miR-33b as the subject of the current study. We found that the expression of miR-33b was significantly downregulated in primary lung squamous cell carcinoma. Furthermore, over-expression of miR-33b in lung squamous cell carcinoma cells remarkably inhibited cell growth in vitro. Mechanistically, TWIST1 is found to be a key transcription factor for the EMT and a direct target gene of miR-33b. Additionally, silencing TWIST1 maybe inhibit the proliferation, migration of lung squamous cell carcinoma, which parallels the function of miR-33b on lung squamous cell carcinoma cells. Importantly, miR-33b levels are negatively correlated with the expression of TWIST1 in human lung squamous cell carcinoma. Collectively, our data indicate that miR-33b is frequently decreased in lung squamous cell carcinoma and showed anti-metastatic activity by downregulating TWIST1, indicating a potential target in the treatment of human lung squamous cell carcinoma.
What problem does this paper attempt to address?